Overview

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

Status:
Completed
Trial end date:
2013-02-08
Target enrollment:
Participant gender:
Summary
This is an observational safety study tracking psoriasis patients on etanercept (Enbrel) for 5 years.
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept